Study of MLN4924 in Adult Patients With Nonhematologic Malignancies

NCT00677170 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Nonhematologic Malignancies

Interventions

DRUG: MLN4924

Sponsor

Millennium Pharmaceuticals, Inc.